Register for our free email digests:
Division of EUSA Pharma
Latest From Cytogen Corp.
EUSA Pharma announced the launch of operations March 23 with a group of products acquired from Jazz Pharmaceuticals and funding from equity investor Essex Woodlands; it is the third specialty pharma company set up by U.K. entrepreneur Bryan Morton.
Jazz strays away from its CNS focus with a $700 million acquisition of EUSA Pharma, adding the specialty pharma’s oncology product to its portfolio.
- Large Molecule
- Medical Devices
- Radiopharmaceuticals, Contrast Agents
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- EUSA Pharma
- Senior Management
Kevin G Lokay, Pres. & CEO
Kevin Bratton, SVP, Fin. & CFO
Stephen A Ross, SVP, Sales & Mktg.
- Contact Info
Phone: (609) 750-8200
650 College Rd. East
Princeton, NJ 08540
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.